Related Experiment Video
Updated: Mar 13, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Pediatric Type 1 Diabetes: Reducing Admission Rates for Diabetes Ketoacidosis.
Jeniece Trast Ilkowitz1, Steven Choi, Michael L Rinke
1The Children's Hospital at Montefiore, Bronx, New York (Mss Ilkowitz and Vandervoot, and Drs Choi, Rinke, and Heptulla); and Albert Einstein College of Medicine, Bronx, New York (Drs Choi, Rinke, and Heptulla).
A comprehensive management plan significantly reduced diabetes ketoacidosis (DKA) hospitalizations and readmissions in children with type 1 diabetes mellitus (T1DM). This approach also shortened the length of stay for DKA patients.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Healthcare Management
Background:
- Diabetes ketoacidosis (DKA) is a severe complication of type 1 diabetes mellitus (T1DM).
- Reducing DKA admissions in pediatric T1DM requires a coordinated and comprehensive management strategy.
- Key metrics for DKA management include admission rates, 30-day readmissions, and length of stay (LOS).
Purpose of the Study:
- To decrease DKA admissions in children with T1DM.
- To reduce 30-day readmissions for DKA.
- To shorten the length of stay (LOS) for DKA admissions.
Main Methods:
- A multipronged intervention was implemented in 2011, including increased insulin pump use, enhanced diabetes education, improved provider access, and patient/family support.
- A before-and-after study design compared outcomes from 2007-2010 (preintervention) to 2012-2014 (postintervention).
- Administrative data were analyzed using Wilcoxon rank sum and Fischer exact tests.
Main Results:
- DKA admissions decreased by 44% postintervention (16.7 to 9.3 per 100 patient-years; P = .006).
- Unique patient 30-day readmissions dropped from 20% to 5% (P = .001).
- Median LOS significantly decreased postintervention (P < .0001), and hemoglobin A1C improved in a subset of patients.
Conclusions:
- Clinical and program interventions significantly reduced DKA hospitalizations, 30-day readmissions, and LOS in pediatric T1DM.
- Continuous quality improvement is essential for optimizing DKA outcomes.
- The study highlights the effectiveness of a multifaceted approach to managing T1DM complications.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational

